Profile data is unavailable for this security.
About the company
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.
- Revenue in USD (TTM)2.02bn
- Net income in USD262.52m
- Incorporated1970
- Employees16.64k
- LocationChemed Corp255 E 5th St Ste 2600CINCINNATI 45202-4138United StatesUSA
- Phone+1 (513) 762-6690
- Fax+1 (302) 655-5049
- Websitehttp://www.chemed.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NeoGenomics, Inc. | 404.55m | -5.36m | 3.96bn | 1.70k | -- | 6.05 | 148.58 | 9.78 | -0.0509 | -0.0509 | 3.79 | 5.93 | 0.4927 | 15.11 | 4.55 | 237,968.80 | -0.6532 | -0.0738 | -0.7051 | -0.083 | 43.29 | 45.16 | -1.33 | -0.1135 | 6.44 | -2.05 | 0.2071 | -- | 47.73 | 36.25 | 31.50 | 47.88 | 39.64 | -- |
| LHC Group, Inc. | 2.06bn | 118.59m | 6.38bn | 15.17k | 53.29 | 4.26 | 38.39 | 3.10 | 3.79 | 3.79 | 65.87 | 47.47 | 0.9392 | -- | 6.90 | 135,794.70 | 6.66 | 6.26 | 8.67 | 7.56 | 36.60 | 37.09 | 7.09 | 4.90 | -- | 16.25 | 0.0186 | 0.00 | 14.93 | 23.18 | 50.57 | 34.39 | -16.35 | -- |
| Encompass Health Corp | 4.60bn | 284.80m | 6.46bn | 31.57k | 22.63 | 4.42 | 10.77 | 1.40 | 2.87 | 2.87 | 46.25 | 14.71 | 0.7474 | -- | 8.77 | 145,774.50 | 5.96 | 7.24 | 7.46 | 8.99 | 96.04 | 96.19 | 7.97 | 8.91 | -- | 3.59 | 0.6577 | 33.98 | 7.66 | 14.17 | 23.32 | 11.49 | 16.55 | 7.12 |
| Irhythm Technologies Inc | 228.19m | -65.10m | 6.93bn | 997.00 | -- | 54.13 | -- | 30.38 | -2.46 | -2.46 | 8.62 | 4.31 | 0.9439 | 15.26 | 8.77 | 228,876.60 | -26.93 | -30.28 | -32.50 | -36.61 | 74.04 | 72.37 | -28.53 | -31.79 | 2.99 | -42.01 | 0.2286 | -- | 45.68 | 58.06 | -8.32 | -- | 106.94 | -- |
| Amedisys Inc | 1.97bn | 128.26m | 7.58bn | 21.30k | 60.40 | 10.51 | 50.06 | 3.85 | 3.87 | 3.87 | 59.47 | 22.22 | 1.38 | -- | 8.07 | 92,584.65 | 9.08 | 8.57 | 12.37 | 11.69 | 40.91 | 41.16 | 6.57 | 4.28 | -- | 17.00 | 0.3584 | 0.00 | 17.63 | 10.18 | 6.27 | 57.73 | -8.06 | -- |
| Chemed Corporation | 2.02bn | 262.52m | 7.65bn | 16.64k | 30.19 | 10.14 | 24.27 | 3.79 | 15.92 | 15.92 | 122.46 | 47.39 | 1.69 | 199.88 | 15.05 | 121,443.10 | 22.01 | 15.65 | 28.49 | 19.61 | 31.74 | 30.62 | 12.99 | 8.63 | 0.5709 | 81.67 | 0.00 | 11.96 | 8.75 | 5.89 | 7.00 | 17.23 | 4.00 | 8.10 |
| Universal Health Services, Inc. | 11.28bn | 734.28m | 10.02bn | 67.70k | 13.91 | 1.76 | 8.02 | 0.8883 | 8.48 | 8.48 | 129.83 | 66.96 | 0.9437 | -- | 7.42 | 166,589.70 | 6.27 | 7.38 | 7.52 | 8.67 | -- | -- | 6.65 | 7.51 | 0.9425 | 7.58 | 0.3799 | 5.61 | 5.63 | 6.76 | 5.20 | 8.32 | 10.13 | 14.87 |
| Molina Healthcare, Inc. | 17.68bn | 797.00m | 10.94bn | 10.00k | 14.18 | 5.46 | 12.44 | 0.6189 | 13.02 | 13.02 | 287.31 | 33.83 | 2.43 | -- | 12.55 | 1,768,400.00 | 10.94 | 3.35 | 21.47 | 8.23 | 18.67 | 15.24 | 4.51 | 1.35 | -- | 13.84 | 0.5056 | 0.00 | -10.91 | 11.73 | 4.24 | 63.76 | -13.09 | -- |
| Davita Inc | 11.52bn | 823.57m | 11.01bn | 65.00k | 13.89 | 4.95 | 6.60 | 0.955 | 6.29 | 6.34 | 86.55 | 17.66 | 0.5874 | 81.67 | 6.09 | 177,290.40 | 5.31 | 4.47 | 7.88 | 5.80 | 31.00 | 29.49 | 9.04 | 7.13 | 1.33 | 5.54 | 0.7327 | 0.00 | -0.1436 | -2.30 | 14.45 | -0.492 | 3.63 | -- |
Data as of Sep 18 2020. Currency figures normalised to Chemed Corp's reporting currency: US Dollar USD
39.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2020 | 1.83m | 11.51% |
| BlackRock Fund Advisorsas of 30 Jun 2020 | 1.37m | 8.64% |
| Neuberger Berman Investment Advisers LLCas of 30 Jun 2020 | 634.01k | 3.98% |
| Acadian Asset Management LLCas of 30 Jun 2020 | 490.60k | 3.08% |
| SSgA Funds Management, Inc.as of 30 Jun 2020 | 400.49k | 2.52% |
| Riverbridge Partners LLCas of 30 Jun 2020 | 336.36k | 2.11% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2020 | 330.93k | 2.08% |
| Renaissance Technologies LLCas of 30 Jun 2020 | 319.00k | 2.00% |
| Capital Research & Management Co. (World Investors)as of 30 Jun 2020 | 279.21k | 1.75% |
| Wells Capital Management, Inc.as of 30 Jun 2020 | 240.99k | 1.51% |
More ▼
Data from 30 Jun 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
